CANTEX PHARMACEUTICALS, INC. — Form D/A
CANTEX PHARMACEUTICALS, INC. of WESTON, FL, a company, filed a Form D amendment with the SEC on 2013-10-31. The offering totals $2.3M, of which $2.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-10-31
- Form: D/A
- Accession: 0001374961-13-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.3M
- Amount sold: $2.3M
- Investors: 6
- Date of first sale: 2013-02-08
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-192030
Issuer
- Name: CANTEX PHARMACEUTICALS, INC.
- CIK: 0001374961
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1792 BELL TOWER LANE, WESTON, FL, 33326
- Phone: 954-315-3660
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Christopher A Kroeger | Director | Redwood City, CA |
| Myles D Greenberg | Director | Salt Lake City, UT |
| Todd C Brady | Director | CRANBURY, NJ |
| Claude G Bertrand | Executive Officer | Weston, FL |
| Stephen G Marcus | Director | Weston, FL |
| Stephen G Marcus | Executive Officer | Weston, FL |
| Neil A Flanzraich | Director | Weston, FL |
| Neil A Flanzraich | Executive Officer | Weston, FL |
| Christopher G Martin | Director | Tucson, AZ |
Other filings by this issuer (3)
More